Muc1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5577-5581

  Kam, Janice L ^a   Regimbald, Lyle H ^a   Hilgers, Joseph H M ^b   Hoffman, Pat ^c   Krantz, Mark J ^d   Longenecker, B Michael ^d   Hugh, Judith C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ELI LILLY AND COMPANY   (United States)

^d Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MUCIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; BREAST ADENOCARCINOMA; CELL ADHESION; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TANDEM REPEAT;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BINDING SITES; BINDING, COMPETITIVE; CA-15-3 ANTIGEN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP; TANDEM REPEAT SEQUENCES; TUMOR CELLS, CULTURED;

EID: 0032403072     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E., and Wilson, D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem., 265: 15286-15293, 1990.
2. Lan, M. S., Batra, S. K., Qi, W., Metzgar, R. S., and Hollingsworth, M. A. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J. Biol. Chem., 265: 15294-15299, 1990.
3. Ligtenberg, M. J. L., Vos, H. L., Gennissen, A. M. C., and Hilkens, J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem., 265: 5573-5578, 1990.
4. Wreschner, D. H., Hareuveni, M., Tsarfaty, I., Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A., and Keydar, I. Human epithelial tumor antigen cDNA sequences. Eur. J. Biochem., 189: 463-473, 1990.
5. Patton, S., Gendler, S. J., and Spicer, A. P. The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim. Biophys. Acta, 1241: 407-424, 1995.
6. Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillett, C., and Taylor-Papadimitriou, J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer, 43: 1072-1076, 1989.
7. Hull, S. R., Bright, A., Carraway, K. L., Abe, M., Hayes, D. F., and Kufe, D. W. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun., 1: 261-267, 1989.
8. Litvinov, S. V., and Hilkens, J. The epithelial sialomucin, episialin, is sialylated during recycling. J. Biol. Chem., 268: 21317-21364, 1993.
9. Regimbald, L. H., Pilarski, L. M., Longenecker, B. M., Reddish, M. A., Zimmermann, G., and Hugh, J. C. The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res., 56: 4244-4249, 1996.
10. Agrawal, B., Krantz, M. J., Reddish, M. A., and Longenecker, B. M. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med., 4: 43-49, 1998.
11. Fontenot, D., Tjandra, N., Bu, D., Ho, C., Montelaro, R. C. and Finn, O. J. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res., 53: 5386-5394, 1993.
12. Fontenot, J. D., Mariappan, S. V., Catasti, P., Domenech, N., Finn, O. J., and Gupta, G. Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope. J. Biomol. Struct. Dyn., 13: 245-260, 1995.
13. Hilgers, J., von Mensdorff-Pouilly, S., Verstraeten, A. A., and Kenemans, P. Quantitation of polymorphic epithelial mucin: a challenge for biochemist and immunologists. Scand. J. Clin. Lab. Invest., 221 (Suppl. 55): 81-86, 1995.
14. Jerome, K. R., Domenech, N., and Finn, O. J. Tumor-specific cytotoxic T cell clones from patient with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol., 151: 1654-1662, 1993.
15. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I. F. C., Bast, R. C., and Finn, O. J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res., 57: 2908-2916, 1991.
16. Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R. S., and Finn. O. J. Humoral immunity against a tandem repeat epitope of a human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res., 54: 2856-2860, 1994.
17. Burchell, J., and Taylor-Papadimitriou, J. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core protein epitopes of the MUC1 gene product. Epithel. Cell Biol., 2: 155-162, 1993.
18. Gold, D. V., and Mattes, M. J. Monoclonal antibody B72.3 reacts with a core region structure of O-linked carbohydrates. Tumor Biol., 9: 137-144, 1988.
19. Bohmig, G. A., Kovarik, J., Holler, W., Pohanka, E., and Zlabinger, G. J. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/ LFA-3 and LFA-1/ICAM-1 in vitro. J. Immunol., 152: 3720-3728, 1994.
20. MacLean, G. D., Reddish, M. A., and Longenecker, B. M. Prognostic significance of preimmunotnerapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J. Immunother., 20: 70-78, 1997.
21. Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. J., and Lotze, M. T. A Phase 1 trial of a synthetic mucin peptide vaccine. J. Surg. Res., 63: 298-304, 1996.
22. Almenar-Queralt, A., Duperray, A., Miles, L. A., Felez, J., and Altieri, D. C. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am. J. Pathol., 147: 1278-1288, 1995.
23. Van de Stolpe, A., and van der Saag, P. T. Intercellular adhesion molecule-1. J. Mol. Med., 74: 13-33, 1996.
24. Reilly, P. L., Woska, J. R., Jr., Jeanfavre, D. D., McNally, E., Rothlein, R., and Bormann, B. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer correlation with binding to LFA-1. J. Immunol., 155: 529-532, 1995.
25. Miller, J., Knorr, R., Ferrone, M., Houdei, R., Carron, C. P., and Dustin, M. L. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med., 182: 1231-1241, 1995.